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Background
Contemporary treatments for Oropharyngeal cancer
(OPSCC) are associated with a number of debilitating
side-effects. Whilst these have a significant impact on
the patient’s quality of life, they are often not measured
in clinical trials of new treatments. In fact, patients and
those involved in their care are rarely involved in such
outcome selection. As a result, the outcomes chosen are
often not relevant to patients or may have little clinical
application, and important outcomes may not be mea-
sured at all. Furthermore, there is no standardisation of
outcome selection and reporting, even amongst trials of
comparable interventions. This reduces the data avail-
able for meta-analyses leading to difficulties in interpret-
ing a treatment’s effectiveness and in making evidence
based healthcare decisions. Outcome reporting bias has
also been highlighted as a significant problem in the
healthcare literature.
Objectives
To develop a Core Outcome Set for OPSCC clinical
trials.
Methods
A systematic review will identify which outcomes are
currently measured in RCTs of interventions for the
treatment of OPSCC. Semi-structured qualitative inter-
views with OPSCC patients and their carers will aim to
establish which outcomes such stakeholders think
should be measured in OPSCC clinical trials. A Delphi
consensus survey, involving patients, carers and clini-
cians, will identify which outcomes are prioritised by the
different stakeholder groups and finally a consensus
meeting involving the same major stakeholders will be
used to establish which outcomes should be included in
the final COS.
Results
Preliminary results of the systematic review and inter-
views will be presented.
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